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A Role for Dentistry in Managing the Oro-Nasopharyngeal
Irradiated Cancer Patient
Michael R. Britt, DDS, MS*

Radiation therapy for oral and nasopharyngeal carcinoma
produces direct and indirect changes in the oral cavity.
Before such therapy is begun, the cancer patient should be
examined by a trained dental specialist so that associated
problems such as oral mucositis, xerostomia, radiation
dental caries, osteoradionecrosis, and ageusia can be ad-

dressed. During and after irradiation therapy as well, the
dental specialist should be involved in the treatment program. In this way, it Is possible to maintain the patient's
dental system through restorative measures, mandatory use
of topical
fluorides,
dental rinses, and
preventive
prophylaxis.

Radiation therapy for oral and nasopharyngeal carcinoma
produces direct and indirect tissue changes in the oral
cavity which cause painful, dysfunctional, esthetic, and
personal problems for the irradiated oral cancer patient.
With the improved prognosis with treatment in these cases,
greater emphasis has shifted to rehabilitation. Such rehabilitation, both during and after radiation, can best be
provided by the combined efforts of medical and dental
personnel. Mucositis, xerostomia, hypogeusia or ageusia,
cervical dental caries, and tissue necrosis may all occur,
with varing severity, in response to radiation therapy ofthe
head and neck. This article reviews the literature on these
common oral changes and presents a dental program to
treat them.

level, time, and intervals of the dosage of irradiation (6,7).
Fortunately, symptoms improve progressively over two to
four weeks (1,6,7).

Xerostomia
Oral irradiated patients commonly experience changes in
salivary flow and consistency. Elow reduction, which begins when salivary glands receive 450R (9), is marked
during the first three to seven days of therapy (8,9) (Fig. 1).
At 5,OOOR to 6,OOOR, permanent salivary gland changes
occur, and xerostomia becomes permanent (1,6,9-12).
Initially in all glands, histopathologic changes consist of
mucous acinar damage, which results in a mucous discharge of " r o p e y " saliva (13). Parotid serous acini become
edematous and devoid of secretory granules (12,13). Serous
flow will decrease more rapidly and more completely than
mucinous flow (2,12). Parenchymal degeneration (13),
acinar necrosis (2,12,13), fibrosis (1,2,6,12,13), adiposis
(2,12), and finally lymphocyte infiltration (12) produce
permanent gland atrophy and advanced dysfunction.

Mucositis
When irradiation is started, a characteristic reddening of
the oral mucosa occurs almost immediately (1,2), and
painful desquamation (1) and cervical odontogenic sensitivity (3) usually follow. During the mucositis, the incidence of infection increases (1), most c o m m o n l y
candidiasis (4,5). The severity of mucositis does not depend on the presence or even the successful management
of the fungal organism (5) but seems to be related to the

Hypogeusia and Ageusia
Changes in taste acuity, as measured by the patient's ability
to taste sucrose, hydrochloric acid, and quinine, begin with
the first 240-400R (14). Loss of acuity then progresses until,
at greater than 3,000R, 500 to 8,000 times the normal
concentrations are required to elicit a normal taste response. When dosages reach 6,000R, ageusia can be permanent (1,2,6,10,11). As the patient recovers, a tenfold
improvement can be expected within 20 to 60 days after
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Fig. 1
Rate of salivary flow reduction. Reprinted w i t h permission from Dreizen
S, et al. Prevention of xerostomia-related dental caries in irradiated
cancer patients. J Dent Res 1977;56(2):99-104. Copyright by Journal of
Dental Research 1977.

Fig. 2
Cervical dental caries in the orofacially irradiated cancer patient.

irradiation (14), and full pretreatment acuity levels can be
expected within two to four months (1,6,14). Hypogeusia
or ageusia is probably caused by the loss of or damage to
microvilli on the tongue papillae (6,11,14).

TABLE I
Bacterial Differences in Healthy and
Disease (caries)-associated Plaque*

Species

Cervical Dental Caries

% Supragingival Organisms
health

A characteristic pattern of dental decay in the orofacially
irradiated cancer patient (1,3,4,7,10,12,15) occurs in cervical areas and on smooth tooth surfaces not normally susceptible to decay (Fig. 2). The carious lesion tends to be
large and broad, sometimes circumscribing the tooth (15)
and causing carious tooth amputations (7).

S. sanguis

-I- +

S. m u t a n s

-i-

Lactobacilli

±

A. viscosus

-

±
-I4- -I-

In the past, it was felt that postirradiation root decay was
the direct effect of ionizing beams on tooth tissue itself, but
subsequent studies have shown that even teeth outside the
ionizing beam become decayed (15). While in vitro studies
generally show that irradiated teeth are not chemically or
structurally altered (12,16,17), one in vivo study on rat teeth
(18) did find some evidence of irradiation changes on tooth
tissue. In contrast to the human condition, however, rodent
teeth are permanently erupting to compensate for occlusal
wear. The irradiation effect in this study was on developing
tooth tissue, not on already formed tissue, as with human
teeth.

not d e t e c t a b l e
less t h a n 1 %
greater t h a n 1 % , less than 1 0 %
greater t h a n 10%

* Reprinted with permission o f t h e author from Loesche WJ. The bacteriology of dental decay and periodontal disease. In: Samuel Baron, ed.
Medical microbiology. Principles and concepts. Menio Park, Cal: Addison-Wesley, in press.

population. This relationship has been demonstrated in
nonirradiated root surface decay (22,23) and in the xerostomic postirrad iation oral environment (24).
S. sanguis is found in very high proportions in the normal
salivary flora (27), while S. mutans and Actinomyces viscosus are found in high numbers on the teeth, unaffected
by the presence of saliva (28,29). S. mutans has been found
in postirrad lated dental plaque in levels 25 times greater
than normal when caries is active (4), while markedly
reduced levels of S. sanguis have been reported in the
irradiated oral cavity whether decay was active or not
(4,24). In pre-irradiation oral samples, S. mutans made up
0.6% of plaque streptococci, whereas, after irradiation, it
made up 44% of plaque streptococci (30).

Postirrad iation decay is, therefore, felt to be due to the
indirect effect of xerostomia, since a similar, if not identical, decay pattern has been reported in-patients with
chronically reduced salivary flow, such as narcotics addicts
(19,20) and those affected with Sjogren's syndrome (21).
Microbiological effects of xerostomia
Table I illustates the important inverse relationship between Streptococcus sanguis and Streptococcus mutans in
caries-free versus carious dental plaque in the general
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Biochemical effects of xerostomia

enzyme activity in S. mutans (45,46). Finally, salivary immunoglobulins can opsonize S. mutans for phagocytosis
(39). The immunoglobulins of whole saliva, probably derived from serum flow (39), are associated with odontoblastic processes of pulpal origin under deep carious lesions
(47), whereas secretory immunoglobulins are associated
only with more shallow lesions (47), such as those seen in
irradiation caries.

The sticky, matted saliva ofthe irradiated patient is high in
nitrogen and organic substances that provide an ideal
bacterial substrate (12). Lactoperoxidase, found in saliva,
inhibits the growth of S. mutans on tooth tissue (33); it
prevents the organism from attaching to tooth surfaces and
permits itto be swallowed (34). However, if salivary flow is
reduced, this mechanism of c o n t r o l l i n g S. mutans is
blunted.

Single immunizations against specific cariogens do not
provide immunity against decay, but rather increase decay
in humans (48) and in gnotobiotic rats (49). If the rapid
microbial changes that occur after irradiation for orofacial
carcinoma can be equated with the effects of single immunization, it would be expected that caries would increase
after irradiation.

Salivary pH in normal individuals is approximately 6.6 (31),
but in the irradiated patient it has consistently been found
to be lower (1,12). With below normal pH, the acidophilic,
cariogenic plaque organisms (31) flourish; below 5.0 to
5.2, calcium and phosphate ions are labilized from the
tooth surface (25). Healthy salivary flow serves to buffer the
acidic pH changes and to replace leached ions because of
the presence of a calcium ion concentration in normal
parotid saliva of 0.75-1.5 mM and phosphate ion concentration of 4-11 mM (32). If salivary flow is reduced,
both ions have lowered availability (32). The net effect of
chronically lowered pH and reduced salivary buffering
would be long-term labilization of calcium and phosphate
from the tooth.

Necrosis
Irradiating oral structures results in tissue edema, endarteritis, small vessel hyalinization, and a general reduction
of effective blood flow (1,3,6). Since tissue repair and
response are physiologically dependent on the amount of
the blood supply and on the severity of the trauma, preventing trauma and infection is the cornerstone of an oral
management program for the irradiated patient.

S. sanguis depends on salivary glycoproteins for agglutination (34,35). After agglutination, tooth colonization occurs
through ionic interaction (35). The ability of S. mutans to
metabolize refined carbohydrate to mucin, a sticky protein,
is an important aspect of its pathogenicity and is unaffected
by salivary flow. A reduction in salivary flow would then
decrease the ability of S. sanguis to compete for tooth
attachment and would thus favor the growth of S. mutans.

The most obvious traumatic episode the irradiated oral
cancer patient experiences is exodontia or tooth extraction.
However, prophylactic tooth extraction for patients scheduled for irradiation is markedly declining in major treatment centers (10). Rather, it is being recommended only
when gross sepsis occurs and when the tooth cannot be
repaired (13,50) or treated endodontically. Ideally, the extraction would take place ten days to two weeks (7,13,50)
before irradiation and an alveolectomy and primary wound
closure (50) would be performed at the same time.

Immunological effects of xerostomia
Resistance to dental decay in normal individuals has been
positively correlated with secretory IgA (S-lgA) and secretory IgM (S-IgM) levels in saliva (36,38), and with serum
IgG (39). S-lgA is found in parotid and minor salivary gland
fluid, predominantly in the latter (40).

A potential source of trauma and discomfort occurs when a
prosthesis rests on the mucosa, especially on the mylohyoid ridge (7). Since this may be an obstacle in the
patient's full rehabilitation, prosthetic service should be
provided by a dental specialist trained in this phase of
rehabilitation.

The relationship between S-lgA and caries activity is also
true for the irradiated patient (4). S-lgA concentration tends
to increase in saliva for about two weeks after irradiation,
but then it tapers off, not returning to pre-irradiation levels
by three months (41). This change would correspond to the
acinar degeneration previously described.

Extraction of teeth has been associated with necrosis in
only 2% (13), 4% (3), and 17% (7) of reported cases.
Radiation dosages were invariably greater than 6,000R
(3,7) and directed primarily at the floor o f t h e mouth (7).
Postirrad iation osteonecrosis occurred from three months
to five years after extraction (6,7). In cases of advanced
periodontitis, teeth have been safely extracted after irradiation using antibiotics and atraumatic methods (3,7). Therefore, realistic attempts can be made to save the teeth ofthe
oropharyngeal cancer patient about to undergo irradiation.

Immunological protection from decay occurs for several
reasons. Because secretory immunoglobulins reduce the
ability of bacteria to adhere to the tooth, the in vitro
adherence of S. mutans is thus reduced (42,43), as is the
epithelial lining adherence of S. mutans, S. mitis, and S.
salivarius (44). Also, S-lgA inhibits the glucosyl transferase
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Infection due to carious pulpal involvement or gross periodontal involvement can also cause necrosis (3,70), but
these problems can easily be managed before irradiation
begins in the same manner as in any non irradiation treatment program. As the evidence grows that periodontal
disease can be controlled conservatively and as stronger,
more accurate, less costly, nonmetal materials are developed, realistic rehabilitation programs can be designed
which are in line economically with the patient's prognosis. Fixed, permanent "temporization" that uses natural
teeth and acrylic bridgework may obviate the need for
mucosal-born prostheses or excessively costly fixed
bridgework.

(7), a 0.4% SnF (51), a 2% NaF gel (13), or a 1% NaF gel
(8,25,27) for five minutes in custom trays (4,8) have all
been used.
Topical fluoride can help to control bacteria on the tooth
by reducing the surface energy of a tooth surface. It binds
preferentially to charged areas and competes with bacteria
for adherence (27). In nonirradiated patients, topical fluoride encourages the growth of S. sanguis over S. mutans
(27,52). However, irradiation favors S. mutans over S.
sanguis (4,24). In spite of this, topical fluoride tends to
arrest shallow existing caries (8), while preventing caries in
the postirrad iation xerostomic patient (4,24).
Topical fluoride seems to have the ability to buffer the acid
pH changes characteristic of the cariogenic S. mutans and
A. viscosus (52,53). The fluoride ion decreases the availability of potassium and reduces the ability of S. mutans to
take up the potassium that is present (53). The potassium
ion is an important cofactor for proper functioning of the
enzymes phosphatase and ATPase (53). In addition, potassium is necessary for S. mutans to use sucrose (25), its
prime cariogenic property. Finally, fluoride inhibits the
enzyme enolase, which interferes with the production of
phosphoenol pyruvate (PEP), a key glycolytic pathway
intermediate (25) in bacterial systems.

Dental Program for Problems of the
Irradiated Oral Cavity
For oral and nasopharyngeal cancer patients who are to
receive radiation therapy, a three-part plan is recommended that manages the patient's dental problems before,
during, and after irradiation (1,3,7,13).
Before irradiation
Diagnostically clear, full mouth, intra-oral or extra-oral
radiographs are mandatory for proper planning of treatment (2,3,7,10,13). By means of radiographs, intrabony
pathology, partially impacted teeth, retained portions of
teeth, and caries extension can all be diagnosed, at least in
part. A concurrent clinical examination will reveal periodontal health, gingival recession, quality of present restorations, and potential prosthetic complications. Extraction of
nontreatable teeth, prophylaxis, restoration, and oral
hygiene procedures should all be accomplished at this time
in the two to three weeks before the patient begins to
receive irradiation.

During irradiation
For this relatively short time, managing the symptoms of
mucositis and c o n t r o l l i n g infection are the primary
concerns.
All oral irradiated patients will experience some mucositis
(7); approximately one half have mild to moderate reactions, while the other half may be severe (7). The common
subjective symptoms of dysgeusia, dysphagia, dysorhexia,
and pain (1,6,7) can be expected to last for ten days to four
weeks (3,6,7). Topical pain relievers, such as viscous xylocaine or Orabase with benzocaine protective paste, are
both effective at controlling acute pain in specific denuded
or desquamated areas and can be applied bythe patient as
needed. More generalized, nonspecific pain can be controlled with dilute salt and soda solutions (1,6,7) or peroxide (3) mouth rinses. The previously mentioned Travad
1500 bag (13) or the equivalent is an excellent means of
using these solutions.

The oral hygiene regimen should be very specific. Brushing
techniques aimed at cervical and sulcular areas (Bass,
Modified Scrub) with a soft, multitufted nylon bristle brush
(Oral B-40, Pro Perio, Butler CUM) will effectively remove
plaque. In anticipation of markedly reduced salivary flow,
an oral lavage should be started. This can easily be done
with a disposable Travad 1500 enema bag or the equivalent
suspended over a basin and filled with one quart of warm
water, in which one teaspoon of baking soda and one-half
teaspoon of salt (13) have been dissolved. Artificial saliva is
also commercially available for this purpose.

If physical signs of infection are present, topical, anticandidial drugs such as Mycostatin oral suspension and systemic antimicrobials may be used.

Finally, as an integral partof a pre-irradiation oral hygiene
program, topical fluoride usage should be begun. Ideally,
plastic custom trays can be made to encourage the patient
to usethe medication at home, since the patient's cooperation will be improved (51). A 3% NaF rinse for one minute

Since topical fluoride may irritate the mucositis, its use may
be delayed until symptoms subside (7). Weekly prophylaxis
with fluoride polish is then recommended until topical
fluoride can again be applied.
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Postirradiation care

In all ofthese ways, a trained dental practitioner can help
the irradiated oronasopharyngeal cancer patient by preventing or alleviating some of the effects of irradiation on
the oral cavity.

At the patient's medical follow-up examination, dental
prophylaxis with fluoridated polish and a dental head and
neck examination can be done. Cood oral hygiene and
continued use of topical fluorides should be stressed, as
well as the long-term need for this type of follow-up.
Prosthetic reconstruction may begin as soon as tissues
return to near normal. Management of osteoradionecrosis,
from simple debridement to resection, should be done by a
trained specialist.
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